Abstract
The control of cell proliferation depends on the interactions between growth factors and their specific receptor-activated signaling pathways. It is well accepted that the local extracellular matrix can modulate cellular responses to a given signal in several ways, such as by modulating the affinity of the ligand for its cognate receptor (1), by binding and limiting availability of a growth factor (1–3), or by influencing proteolytic processing and internalization (3). However, it has only recently been shown that “structural” components of the extracellular matrix can interact directly with, and activate, receptor tyrosine kinases (RTKs). This was first shown by Vogel et al. and Shrivastava et al., who demonstrated that the “orphan” receptor tyrosine kinases DDR1 and DDR2 in fact bind fibrillar collagen (4,5). This binding required the native triplehelical structure of collagen and showed much slower kinetics than observed with other ligand-receptor interactions (5). Decorin (6–8), a member of a family of small leucine-rich proteoglycans (3), binds to fibrillar collagen and is an important regulator of matrix assembly (9–11). Decorin content is elevated in the tumor stroma of colon cancer (11), and ectopic expression of decorin inhibits cell growth (11–13). The growth-suppressive properties of decorin are independent of p53 or retinoblastoma proteins but require functional p21 protein (Waf1/Cip1/Sdi1) (13–16).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Iozzo, R. V. and Murdoch, A. D. (1996) Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10, 598–614.
Somasundaram, R. and Schuppan, D. (1996) Type I, II, III, IV, V, and VI collagens serve as extracelular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J. Biol. Chem. 271 (43), 26884–26891.
Iozzo, R. V. (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol. 32, 141–174.
Vogel, W., Gish, G. D., Alves, F., and Pawson T. (1997) The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell. 1, 13–23, 1997.
Shrivastava, A., Radziejewski, C., Campbell, E., Kovac, L., McGlynn, M., Ryan, T. E., Davis, S., Goldfarb, M. P., Glass, D. J., Lemke, G., and Yancopoulos G. D. (1997) An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell. 1, 25–34.
Krusius, T. and Ruoslahti, E. (1986) Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc. Natl. Acad. Sci. (USA). 83, 7683–7687.
Day, A. A., McQuillan, C. I., Termine, J. D., and Young, M. R. (1987) Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. Biochem. J. 248, 801–805.
Fisher, L. W., Termine, J. D., and Young, M. F. (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 264, 4571–4576.
Toole, B. P. and Lowther, D. A. (1968) The effect of chondroitin sulphate-protein in the formation of collagen fibrils in vitro. Biochem. J. 109, 857–866.
Vogel, K. G., Paulsson, M., and Heinegård, D. (1984) Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J. 223, 587–597.
Adany, R., Heimer, R., Caterson, B., Sorrell, J. M., and Iozzo. R. V. (1990) Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels. J. Biol. Chem. 265, 11389–11396.
Santra, M., Skorski, T., Calabretta, B., Lattime, E. C., and Iozzo, R. V. (1995) De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. (USA) 92, 7016–7020.
Santra, M., Mann, D. M., Mercer, E. W., Skorski, T., Calabretta, B., and Iozzo, R. V. (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest. 100, 149–157.
DeLuca, A., Santra, M., Baldi, A., Giordano, A., and Iozzo, R. V. (1996)Decorin-induced growth suppression is associated with upregulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem. 271, 18961–18965.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75, 805–816.
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, apotential mediator of p53 tumor suppression. Cell. 75, 817–825.
Moscatello, D. K., Santra, M., Mann, D. M., McQuillan, D. J., Wong, A. J., and Iozzo, R. V. (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101, 406–412.
Iozzo, R. V., Moscatello, D. K., McQuillan, D. J., and Eichstetter, I. (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274, 4489–4492.
Weber, W., Gill, G. G., and Spiess, J. (1984) Production of an epidermal growth factor receptor-related protein. Science 224, 294–297.
Fan, Z., Lu, Y., Wu, X., and Mendelsohn, J. (1994) Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squa-mous carcinoma cells J. Biol. Chem. 269, 27595–27602.
Ramamurthy, P., Hocking, A. M., and McQuillan, D. J. (1996) Recombinant decorin glycoforms. Purification and structure. J. Biol. Chem. 271, 19578–19584.
Hocking, A. M., Strugnell, R. A., Ramamurthy, P., and McQuillan, D. J. (1996) Eukaryotic expression of recombinant biglycan. Post-translational processing and the importance of secondary structure for biological activity. J. Biol. Chem. 271, 19571–19577.
Mann, D. M., Yamaguchi, Y., Bourdon, M. A., and Ruoslahti, E. (1990) Analysis of gly-cosaminoglycan substitution in decorin by site-directed mutagenesis. J. Biol. Chem. 265, 5317–5323.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Moscatello, D.K., Iozzo, R.V. (2001). Interaction of Proteoglycans with Receptor Tyrosine Kinases. In: Iozzo, R.V. (eds) Proteoglycan Protocols. Methods in Molecular Biology™, vol 171. Humana Press. https://doi.org/10.1385/1-59259-209-0:427
Download citation
DOI: https://doi.org/10.1385/1-59259-209-0:427
Publisher Name: Humana Press
Print ISBN: 978-0-89603-759-5
Online ISBN: 978-1-59259-209-8
eBook Packages: Springer Protocols